ES2177509T3 - Empleo de anticuerpos para la vacunacion contra el cancer. - Google Patents

Empleo de anticuerpos para la vacunacion contra el cancer.

Info

Publication number
ES2177509T3
ES2177509T3 ES00906191T ES00906191T ES2177509T3 ES 2177509 T3 ES2177509 T3 ES 2177509T3 ES 00906191 T ES00906191 T ES 00906191T ES 00906191 T ES00906191 T ES 00906191T ES 2177509 T3 ES2177509 T3 ES 2177509T3
Authority
ES
Spain
Prior art keywords
employment
antibodies
against cancer
vaccination against
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00906191T
Other languages
English (en)
Inventor
Helmut Eckert
Hans Loibner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH
Original Assignee
Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH filed Critical Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH
Application granted granted Critical
Publication of ES2177509T3 publication Critical patent/ES2177509T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Empleo de un anticuerpo, que está dirigido contra el antígeno de la membrana celular Ep-CAM, para la preparación de un medicamento para la inmunización activa, profiláctica y/o terapéutica, contra el cáncer.
ES00906191T 1999-01-13 2000-01-12 Empleo de anticuerpos para la vacunacion contra el cancer. Expired - Lifetime ES2177509T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5199 1999-01-13

Publications (1)

Publication Number Publication Date
ES2177509T3 true ES2177509T3 (es) 2002-12-16

Family

ID=4178206

Family Applications (2)

Application Number Title Priority Date Filing Date
ES02005394T Expired - Lifetime ES2236375T3 (es) 1999-01-13 2000-01-12 Uso de anticuerpos para la vacunacion contra el cancer.
ES00906191T Expired - Lifetime ES2177509T3 (es) 1999-01-13 2000-01-12 Empleo de anticuerpos para la vacunacion contra el cancer.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES02005394T Expired - Lifetime ES2236375T3 (es) 1999-01-13 2000-01-12 Uso de anticuerpos para la vacunacion contra el cancer.

Country Status (28)

Country Link
US (3) US7691372B2 (es)
EP (2) EP1140168B1 (es)
JP (1) JP4774551B2 (es)
KR (1) KR100771752B1 (es)
CN (1) CN1188169C (es)
AT (2) ATE286745T1 (es)
AU (1) AU768515B2 (es)
CA (1) CA2360382C (es)
CZ (1) CZ302801B6 (es)
DE (2) DE50000243D1 (es)
DK (2) DK1140168T3 (es)
EE (1) EE05474B1 (es)
ES (2) ES2236375T3 (es)
HK (1) HK1044487B (es)
HR (1) HRP20010526A2 (es)
HU (1) HU226150B1 (es)
ID (1) ID30223A (es)
IL (2) IL144265A0 (es)
IS (1) IS5998A (es)
MX (1) MXPA01007148A (es)
NO (1) NO329917B1 (es)
NZ (1) NZ512722A (es)
PL (1) PL201533B1 (es)
PT (2) PT1230932E (es)
SI (2) SI1230932T1 (es)
SK (1) SK286627B6 (es)
TR (1) TR200102034T2 (es)
WO (1) WO2000041722A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302801B6 (cs) * 1999-01-13 2011-11-16 Igeneon Krebs-Immuntherapie Forschungs Und Entwicklungs-Ag Použití protilátky namírené proti antigenu bunecné membrány Ep-CAM pro výrobu farmaceutického prostredku
AT410172B (de) * 2000-03-21 2003-02-25 Igeneon Gmbh Verfahren zur herstellung einer vakzineformulierung
AT502293B1 (de) * 2002-05-15 2008-03-15 Igeneon Krebs Immuntherapie Immunogener, monoklonaler antikörper
AT500647A1 (de) * 2002-05-21 2006-02-15 Igeneon Krebs Immuntherapie Verwendung eines impfstoffes
AT500650B1 (de) * 2003-04-17 2009-11-15 Altropus Gmbh Immunogener rekombinanter antikörper
AT500651B9 (de) * 2003-05-27 2010-04-15 Altropus Gmbh Aktiv immunisierender antikörper
JP2008505943A (ja) 2004-07-14 2008-02-28 イゲネーオン・クレープス−イムンテラピー・フォルシュングス−ウント・エントヴィックルングス−アクチェンゲゼルシャフト グリコシル化抗体
ATE483473T1 (de) * 2004-07-20 2010-10-15 Altropus Gmbh Verwendung von antikörpern in einer sehr geringen dosis zur impfung gegen krebs
CA2605749C (en) * 2005-04-26 2015-06-30 Eisai Co., Ltd. Compositions and methods for cancer immunotherapy
EP2004695A2 (en) 2005-07-08 2008-12-24 Xencor, Inc. Optimized anti-ep-cam antibodies
EP1762575A1 (en) * 2005-09-12 2007-03-14 Ganymed Pharmaceuticals AG Identification of tumor-associated antigens for diagnosis and therapy
AT504231A1 (de) 2006-10-03 2008-04-15 Hans Dr Loibner Prädiktive parameter
BRPI0821165B8 (pt) 2007-12-07 2021-05-25 Nutricia Nv uso de uma composição
CA2744103C (en) 2009-02-24 2018-01-02 Esbatech, An Alcon Biomedical Research Unit Llc Methods for identifying immunobinders of cell-surface antigens
US8887373B2 (en) 2012-02-24 2014-11-18 Covidien Lp Vessel sealing instrument with reduced thermal spread and method of manufacture therefor
US20140276968A1 (en) * 2013-03-14 2014-09-18 Ethicon, Inc. Applicator systems for surgical fasteners
US10196458B2 (en) * 2013-07-26 2019-02-05 The Regents Of The University Of California Anti-immunoglobulin E antibodies and methods of using thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (en) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen
US5270202A (en) 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5798100A (en) * 1994-07-06 1998-08-25 Immunomedics, Inc. Multi-stage cascade boosting vaccine
WO1997005597A1 (en) * 1995-07-31 1997-02-13 Litton Systems Canada Limited Flat panel pixel array incorporating photoconductive switches
EP0857176A1 (en) * 1995-10-25 1998-08-12 Centocor B.V. HUMAN EPITHELIAL ANTIGEN Ep-CAM DERIVED PEPTIDES AND THEIR USE
US6235280B1 (en) 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
IL121041A0 (en) * 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
US6274143B1 (en) * 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
IL139700A (en) * 1998-06-15 2005-09-25 Altarex Medical Corp Immunotherapeutic composition for the treatment of prostate cancer
CZ302801B6 (cs) * 1999-01-13 2011-11-16 Igeneon Krebs-Immuntherapie Forschungs Und Entwicklungs-Ag Použití protilátky namírené proti antigenu bunecné membrány Ep-CAM pro výrobu farmaceutického prostredku
WO2001087233A2 (en) 2000-05-16 2001-11-22 New York University Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof

Also Published As

Publication number Publication date
IL144265A (en) 2006-08-20
EE200100366A (et) 2002-10-15
MXPA01007148A (es) 2002-03-27
HU226150B1 (en) 2008-05-28
IL144265A0 (en) 2002-05-23
AU768515B2 (en) 2003-12-18
PL364747A1 (en) 2004-12-13
DK1140168T3 (da) 2002-09-30
EP1230932A2 (de) 2002-08-14
CN1344167A (zh) 2002-04-10
DK1230932T3 (da) 2005-04-25
NZ512722A (en) 2003-07-25
DE50009240D1 (de) 2005-02-17
EP1230932B1 (de) 2005-01-12
EP1140168A1 (de) 2001-10-10
ATE286745T1 (de) 2005-01-15
ES2236375T3 (es) 2005-07-16
NO20013093L (no) 2001-09-10
HK1044487B (zh) 2005-09-16
HRP20010526A2 (en) 2002-08-31
CZ20012581A3 (cs) 2002-01-16
CA2360382C (en) 2011-05-24
HK1044487A1 (en) 2002-10-25
JP4774551B2 (ja) 2011-09-14
SI1140168T1 (en) 2002-10-31
PT1230932E (pt) 2005-04-29
SK9642001A3 (en) 2002-03-05
CN1188169C (zh) 2005-02-09
KR20010101446A (ko) 2001-11-14
TR200102034T2 (tr) 2001-11-21
US20070224202A1 (en) 2007-09-27
EE05474B1 (et) 2011-10-17
SI1230932T1 (en) 2005-06-30
PL201533B1 (pl) 2009-04-30
CA2360382A1 (en) 2000-07-20
US20120003232A1 (en) 2012-01-05
US20100233178A1 (en) 2010-09-16
SK286627B6 (sk) 2009-02-05
HUP0200527A2 (en) 2002-06-29
IS5998A (is) 2001-07-10
NO329917B1 (no) 2011-01-24
WO2000041722A1 (de) 2000-07-20
AU2796400A (en) 2000-08-01
PT1140168E (pt) 2002-11-29
CZ302801B6 (cs) 2011-11-16
JP2002534481A (ja) 2002-10-15
US8444974B2 (en) 2013-05-21
EP1230932A3 (de) 2003-11-26
US7691372B2 (en) 2010-04-06
KR100771752B1 (ko) 2007-10-30
EP1140168B1 (de) 2002-06-26
ATE219687T1 (de) 2002-07-15
DE50000243D1 (de) 2002-08-01
NO20013093D0 (no) 2001-06-21
ID30223A (id) 2001-11-15

Similar Documents

Publication Publication Date Title
TR200001253T2 (tr) Tümöre özel antijenler
BRPI0412245A (pt) anticorpos de rg1 e usos destes
BR0114786A (pt) Composição imunogênica, método de tratamento de um paciente que sofre de, ou que é suscetìvel a, um câncer, e, uso de uma combinação de uma saponina, um oligotìdeo imunoestimulador e um antìgeno de câncer, e, método para a manufatura de uma composição
IL144265A0 (en) Use of antibodies for the vaccination against cancer
NO20010922L (no) Fremgangsmåte for DNA vaksinering
DK1276896T3 (da) Epitop-synkronisering i antigen-præsenterende celler
AR001686A1 (es) Una composición vacuna un proceso para prepararla y su uso para la fabricación de una vacuna
ES2152483T3 (es) Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b.
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
WO2001058485A3 (en) Prophylactic and therapeutic antibodies against vaccina virus antigens
BR9609072A (pt) Fatores de ativação macrófagos derivados de proteìna ligada a vitamina d clonada
AR030829A1 (es) Una formulacion de vacuna, procedimiento para la produccion de la misma, uso de dicha preparacion y un estuche para su administracion via intranasal
BR0010711A (pt) Uso de moléculas co-estimulatórias solúveis para intensificar respostas imunes
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
WO2000069915A3 (en) COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
SE9604581D0 (sv) An agent against cancer and virus infections
BR0116010A (pt) Kit imunoterapêutico para o tratamento de tumores
AR016396A1 (es) Homogeneizado preparado a partir de celulas de neospora, vacuna, procedimiento para prepararlo, equipo de vacunacion y anticuerpo.
ATE193974T1 (de) Chlamydia impfstoffen
RU94046321A (ru) Моноклональные муриновые антиидиотипические антитела, способ их получения и их применение, способы иммунизации и фармацевтический состав на их основе
BR0007814A (pt) Uso de anticorpos para a vacinação contra câncer
AR020765A1 (es) Anticuerpos monoclonales humanos contra el antigeno de tumor uk114 y celulas de linfocitos e hibridomas para su produccion
PT1194450E (pt) Vacina inactivada contra a calicivirose felina
GT199600036A (es) Vacunacion in ovo contra la coccidiosis.
ECSP003404A (es) Solucion acuosa estable de em 12 y procedimiento de preparacion de dicha solucion